Triple

T9863635

Position	Surface form	Disambiguated ID	Type / Status
Subject	Rutgers Biomedical and Health Sciences	`E239776`	entity
Predicate	hasPart	`P35`	FINISHED
Object	Center for Advanced Biotechnology and Medicine The Center for Advanced Biotechnology and Medicine is a Rutgers research institute focused on cutting-edge biomedical science and biotechnology to improve human health.	`E239776`	NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini

Instruction

Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).

Input

Phrase: Center for Advanced Biotechnology and Medicine | Statement: [Rutgers Biomedical and Health Sciences, hasPart, Center for Advanced Biotechnology and Medicine]

NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07

Target entity: Center for Advanced Biotechnology and Medicine
Context triple: [Rutgers Biomedical and Health Sciences, hasPart, Center for Advanced Biotechnology and Medicine]

A. Center for Cellular and Molecular Therapeutics
The Center for Cellular and Molecular Therapeutics is a research institute specializing in developing gene and cell-based therapies for pediatric and genetic diseases.
B. Center for Biotechnology and Interdisciplinary Studies
The Center for Biotechnology and Interdisciplinary Studies is a major research facility focused on cutting-edge biotechnology and cross-disciplinary scientific collaboration.
C. Feinstein Institutes for Medical Research
The Feinstein Institutes for Medical Research is a leading biomedical research organization in New York focused on advancing medical science and improving patient care through translational and clinical research.
D. Rutgers Biomedical and Health Sciences
Rutgers Biomedical and Health Sciences is the division of Rutgers University that encompasses its medical, dental, nursing, pharmacy, public health, and allied health schools and research institutes.
E. Center for Health and Biosciences
The Center for Health and Biosciences is a research and policy institute focused on health care, biomedical innovation, and related public policy issues.
F. None of above. chosen
G. Unsure - the case is ambiguous/there is not enough information to decide.

NEDg Description generation gpt-5.1

Instruction

Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"

Input

Entity: Center for Advanced Biotechnology and Medicine
Triple: [Rutgers Biomedical and Health Sciences, hasPart, Center for Advanced Biotechnology and Medicine]

Generated description

The Center for Advanced Biotechnology and Medicine is a Rutgers research institute focused on cutting-edge biomedical science and biotechnology to improve human health.

NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07

Target entity: Center for Advanced Biotechnology and Medicine
Target entity description: The Center for Advanced Biotechnology and Medicine is a Rutgers research institute focused on cutting-edge biomedical science and biotechnology to improve human health.

A. Center for Cellular and Molecular Therapeutics
The Center for Cellular and Molecular Therapeutics is a research institute specializing in developing gene and cell-based therapies for pediatric and genetic diseases.
B. Center for Biotechnology and Interdisciplinary Studies
The Center for Biotechnology and Interdisciplinary Studies is a major research facility focused on cutting-edge biotechnology and cross-disciplinary scientific collaboration.
C. Feinstein Institutes for Medical Research
The Feinstein Institutes for Medical Research is a leading biomedical research organization in New York focused on advancing medical science and improving patient care through translational and clinical research.
D. Rutgers Biomedical and Health Sciences chosen
Rutgers Biomedical and Health Sciences is the division of Rutgers University that encompasses its medical, dental, nursing, pharmacy, public health, and allied health schools and research institutes.
E. Center for Health and Biosciences
The Center for Health and Biosciences is a research and policy institute focused on health care, biomedical innovation, and related public policy issues.
F. None of above.

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step	Stage	Batch ID	Status	When
creating	Elicitation	`batch_69ca84e7506c819095cbde4ff16512bb`	completed	March 30, 2026, 2:12 p.m.
NER	Named-entity recognition	`batch_69cdb3b927d08190a45ff68de3954e8f`	completed	April 2, 2026, 12:09 a.m.
NED1	Entity disambiguation (via context triple)	`batch_69d1e447d3dc819090268f7d14ba3be4`	completed	April 5, 2026, 4:25 a.m.
NEDg	Description generation	`batch_69d1e4bdd10881909d03bac4912e8e0a`	completed	April 5, 2026, 4:27 a.m.
NED2	Entity disambiguation (via description)	`batch_69d1e5358b148190a6e432aac9d02544`	completed	April 5, 2026, 4:29 a.m.

Created at: March 30, 2026, 8:35 p.m.